List view / Grid view

Valeant Pharmaceuticals International Inc.



FDA approves new psoriasis drug that induced suicide in trial

17 February 2017 | By Niamh Marriott, Digital Editor

The US Food and Drug Administration (FDA) has approved Valeant’s Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken by mouth or…